Alnylam Pharmaceuticals
ALNY
#544
Rank
A$64.21 B
Marketcap
A$486.06
Share price
-0.06%
Change (1 day)
8.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company